Tag Archives: Patients

Apple-backed Stanford study suggests iPhone, Apple Watch could remotely monitor heart patients’ frailty

iPhones and Apple Watches could enable at-home assessment of cardiovascular disease patients’ frailty via sensor data and an app-guided version of the six-minute walk test (6MWT), a traditionally clinic-based assessment of a person’s functional capacity, according to data published yesterday in PLoS One. Conducted by Stanford University researchers and funded by Apple, the study provided 110… Read More »

Retrospective refusal of payment based upon final diagnosis compromises patients’ welfare

My patient was very upset. The 34-year-old mother of two young children had come to the emergency department (ED) with abdominal pain despite her COVID-19 concerns. I had just told her that she had a benign ovarian cyst rather than the life-threatening condition that she had imagined. She was happy with the diagnosis, but she… Read More »

FDA Approves Fotivda (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma

FDA Approves Fotivda (tivozanib) for the Treatment of Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma BOSTON–(BUSINESS WIRE) March 10, 2021 — AVEO Oncology (Nasdaq: AVEO) today announced that the U.S. Food and Drug Administration (FDA) has approved Fotivda (tivozanib) for the treatment of adults with relapsed or refractory advanced renal cell carcinoma… Read More »

FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency (MoCD) Type A

FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency (MoCD) Type A PALO ALTO, February 28, 2021 – BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio) and affiliate Origin Biosciences, Inc. (Origin) today announced the U.S. Food and Drug Administration (FDA) has approved Nulibry (fosdenopterin) for Injection as the first… Read More »

Breast Cancer Awareness Month 2020: Nearly 30% of Breast Cancer Patients Gain Weight After Receiving Chemotherapy

Washington, October 25: Nearly 30 per cent patients with breast cancer gained weight after receiving chemotherapy treatment, suggested a study. The study was published in the journal BMC Medicine. Beyond weight gain, chemotherapy is also known to increase the risk of high blood pressure and glucose intolerance, a prediabetes condition. Although this is a familiar… Read More »